Newly filed internal documents show how Google viewed its work with schools as a way of turning children into lifelong customers — while the company simultaneously acknowledged research suggesting ...

An internal Immigration and Customs Enforcement document in May shows that ICE told officers and agents they can forcibly enter homes of people subject to deportation without warrants signed by judges ...

The Immigration and Customs Enforcement (ICE) officer who shot Renee Good, a Minneapolis woman whose death has sparked outrage across the country, suffered from internal bleeding after the incident, a ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

‘A compromised n8n instance doesn’t just mean losing one system — it means handing attackers the keys to everything,’ security researchers wrote of the 10.0 severity vulnerability. Researchers have ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 12 Best Genomics Stocks to Invest In. Cathie Wood’s ARK Investment acquired 755,000 shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ...

TL;DR: Make AI even more efficient with this lifetime subscription to 1min.AI’s Advanced Business Plan, on sale now $74.97 (reg. $540) through January 31. It’s easy to get overwhelmed by all the AI ...

Background: Accurate documentation of clinical teaching sessions is critical, particularly in multilingual contexts. Recent advances in smartphone-based speech recognition and large language models ...

OpenAI released new data Monday showing enterprise usage of its AI tools has surged dramatically over the past year, with ChatGPT message volume growing 8x since November 2024 and workers reporting ...

Hi, everyone, and welcome. I'm Najat Khan, Recursion's Chief R&D and Chief Commercial Officer and incoming CEO and President. Let's jump right in. Today is an important moment for Recursion, for our ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer discussed, along with the tech battleground. Answering a caller’s query about the stock during the lightning round, Cramer ...